Cargando…
Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis
Approximately 30% of patients treated with ipilimumab will develop gastrointestinal toxicity. The immunological drivers that underpin the clinical observations in human tissues are poorly understood. We report here on the immune consequences of ipilimumab treatment in the colorectal mucosa of patien...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048766/ https://www.ncbi.nlm.nih.gov/pubmed/27757302 http://dx.doi.org/10.1080/2162402X.2016.1209615 |